logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

Regulatory Highlights

delete2023-03-03
delete0
PRE
AI
A
Andrew Teasdale
K
Kevin S. Hughes
DOI：10.1021/acs.oprd.3c00055delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
In this edition we look at two specific areas. First, we consider the revision of ICH Q2(R1) and the development of ICH Q14 as they have reached the key ICH milestone of Step 2 publication for public consultation. Second, we discuss the evolving and critical area of the environmental impact of the pharmaceutical industry, highlighting in particular the impact of solvent use and the need to reduce barriers to allow recycling and reuse, which in turn will reduce the burden imposed by the need for virgin solvents. We examine how guidance relating to quality can impact this and discuss the need for a far more holistic approach to the use of recycling.

Journal

O
Organic Process Research and Development
IF:
3.5
Papers:
5.8K
Citations:
1.1W

Organization

No organization information available